Tuesday, March 25, 2025 3/25/2025

Identification of mechanisms by which cytisine and estrogen inhibit ER stress and exert neuroprotection in Parkinson's disease

Award Number: R01NS115809
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

Parkinson’s disease (PD) is the second most common neurodegenerative disorder, predicted to affect over 12 million people worldwide by 2040. There is no cure for PD and current treatments are merely symptomatic, which underscores an urgent and unmet need for neuroprotective drugs. One major barrier for the inability to develop effective and clinically translatable neuroprotective drugs is that no single animal model recapitulates the complex process that leads to dopaminergic (DA) neuron loss in PD. Therefore, most drugs that succeed in preclinical animal models fail to work in PD patients. The current proposal addresses this barrier by focusing on hyperactivated endoplasmic reticulum (ER) stress, which is an established convergent mechanism downstream of multiple PD-related toxicities. ER stress consists of three signaling arms that culminate in the translocation of three key proteins – ATF6, XBP1, and CHOP into the nucleus of DA neurons. Moderate activation of ATF6 and XBP1 is neuroprotective, while chronic, uncontrolled activation of these proteins leads to DA cell death. By contrast, activation of CHOP invariably causes cell death. Experiments showed that the nicotinic compound cytisine causes an upregulation of specialized structures called ER exit sites (ERES), and this is associated with an inhibition of ATF6 and XBP1. Surprisingly, experiments in a 6-hydroxydopamine (6-OHDA)-induced preclinical toxin model of PD showed that cytisine is neuroprotective only in female mice. Additional preliminary experiments showed that 17-β-estradiol inhibits CHOP expression in DA neurons, which fits with strong sex-differences observed in the incidence and phenotype of PD, with men being more prone to developing PD than women. Based on these data, this proposal hypothesizes that cytisine and estrogen exert neuroprotection in female mice by synergistically inhibiting all three arms (ATF6, XBP1 and CHOP) of hyperactivated ER stress in DA neurons. Experiments are proposed to determine the extent to which cytisine requires ERES for exerting neuroprotection by specifically deleting ERES in DA neurons or by using nicotinic compounds that cannot upregulate ERES. Female mice will be ovariectomized to determine mechanisms by which specific subtypes of estrogen receptors exert neuroprotection in female mice. On completing experiments in this proposal, key signaling targets through which cytisine and estrogen mediate neuroprotective effects will be identified. Success in this proposal will lay groundwork for the long-term goal of discovering clinically translatable neuroprotective PD drugs that work in both men and women.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $341,317 )
2024	2024	TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER	6003 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	5	5/3/2024	NON-COMPETING CONTINUATION	$24,631
2024	2024	TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER	6003 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	5	1/12/2024	NON-COMPETING CONTINUATION	$316,686
														Subtotal = $341,317

Issue Date FY: 2023 ( Subtotal = $352,071 )
2023	2023	TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER	6003 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	4	2/20/2023	NON-COMPETING CONTINUATION	$352,071
														Subtotal = $352,071

Issue Date FY: 2022 ( Subtotal = $352,259 )
2022	2022	TEXAS A&M UNIVERSITY SYSTEM, THE	8441 RIVERSIDE PARKWAY BLDG 1 STE 3100	BRYAN	TX	77807	BRAZOS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	3	3/28/2022	NON-COMPETING CONTINUATION	$35,226
2022	2022	TEXAS A&M UNIVERSITY SYSTEM, THE	8441 RIVERSIDE PARKWAY BLDG 1 STE 3100	BRYAN	TX	77807	BRAZOS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	3	2/15/2022	NON-COMPETING CONTINUATION	$317,033
														Subtotal = $352,259

Issue Date FY: 2021 ( Subtotal = $352,439 )
2021	2021	TEXAS A&M UNIVERSITY SYSTEM, THE	8441 RIVERSIDE PARKWAY BLDG 1 STE 3100	BRYAN	TX	77807	BRAZOS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	1/28/2021	NON-COMPETING CONTINUATION	$352,439
														Subtotal = $352,439

Issue Date FY: 2020 ( Subtotal = $350,326 )
2020	2020	TEXAS A&M UNIVERSITY SYSTEM, THE	8441 RIVERSIDE PARKWAY BLDG 1 STE 3100	BRYAN	TX	77807	BRAZOS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	2/6/2020	NEW	$350,326
														Subtotal = $350,326

Grand Total All Awards = $1,748,412

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Identification of mechanisms by which cytisine and estrogen inhibit ER stress and exert neuroprotection in Parkinson's disease

Award Number: R01NS115809

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer